Noise Cancellation: Viral Fine Tuning of the Cellular Environment for Its Own Genome Replication

1. SancarA

Lindsey-BoltzLA

Unsal-KacmazK

LinnS

2004 Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73 39 85

2. RouseJ

JacksonSP

2002 Interfaces between the detection, signaling, and repair of DNA damage. Science 297 547 551

3. HaffnerR

OrenM

1995 Biochemical properties and biological effects of p53. Curr Opin Genet Dev 5 84 90

4. KoLJ

PrivesC

1996 p53: puzzle and paradigm. Genes Dev 10 1054 1072

5. StrackerTH

CarsonCT

WeitzmanMD

2002 Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418 348 352

6. DahlJ

YouJ

BenjaminTL

2005 Induction and utilization of an ATM signaling pathway by polyomavirus. J Virol 79 13007 13017

7. ShirataN

KudohA

DaikokuT

TatsumiY

FujitaM

2005 Activation of ataxia telangiectasia-mutated DNA damage checkpoint signal transduction elicited by herpes simplex virus infection. J Biol Chem 280 30336 30341

8. GasparM

ShenkT

2006 Human cytomegalovirus inhibits a DNA damage response by mislocalizing checkpoint proteins. Proc Natl Acad Sci U S A 103 2821 2826

9. KudohA

FujitaM

ZhangL

ShirataN

DaikokuT

2005 Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment. J Biol Chem 280 8156 8163

10. YoungLS

RickinsonAB

2004 Epstein-Barr virus: 40 years on. Nat Rev Cancer 4 757 768

11. AdamsA

1987 Replication of latent Epstein-Barr virus genomes in Raji cells. J Virol 61 1743 1746

12. DaikokuT

KudohA

FujitaM

SugayaY

IsomuraH

2005 Architecture of replication compartments formed during Epstein-Barr virus lytic replication. J Virol 79 3409 3418

13. JoabI

NicolasJC

SchwaabG

de-TheG

ClausseB

1991 Detection of anti-Epstein-Barr-virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. Int J Cancer 48 647 649

14. FengWH

CohenJI

FischerS

LiL

SnellerM

2004 Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. J Natl Cancer Inst 96 1691 1702

15. HammerschmidtW

SugdenB

1988 Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55 427 433

16. FlemingtonEK

GoldfeldAE

SpeckSH

1991 Efficient transcription of the Epstein-Barr virus immediate-early BZLF1 and BRLF1 genes requires protein synthesis. J Virol 65 7073 7077

17. KudohA

FujitaM

KiyonoT

KuzushimaK

SugayaY

2003 Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication. J Virol 77 851 861

18. TsurumiT

FujitaM

KudohA

2005 Latent and lytic Epstein-Barr virus replication strategies. Rev Med Virol 15 3 15

19. LiM

ChenD

ShilohA

LuoJ

NikolaevAY

2002 Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416 648 653

20. SaridakisV

ShengY

SarkariF

HolowatyMN

ShireK

2005 Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol Cell 18 25 36

21. SivachandranN

SarkariF

FrappierL

2008 Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathog 4 e1000170

22. CayrolC

FlemingtonE

1996 G0/G1 growth arrest mediated by a region encompassing the basic leucine zipper (bZIP) domain of the Epstein-Barr virus transactivator Zta. J Biol Chem 271 31799 31802

23. CayrolC

FlemingtonEK

1996 The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J 15 2748 2759

24. MauserA

Holley-GuthrieE

SimpsonD

KaufmannW

KenneyS

2002 The Epstein-Barr virus immediate-early protein BZLF1 induces both a G(2) and a mitotic block. J Virol 76 10030 10037

25. MauserA

SaitoS

AppellaE

AndersonCW

SeamanWT

2002 The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms. J Virol 76 12503 12512

26. SatoY

ShirataN

MurataT

NakasuS

KudohA

2010 Transient increases in p53-responsible gene expression at early stages of Epstein-Barr virus productive replication. Cell Cycle 9 807 814

27. ChangSS

LoYC

ChuaHH

ChiuHY

TsaiSC

2008 Critical role of p53 in histone deacetylase inhibitor-induced Epstein-Barr virus Zta expression. J Virol 82 7745 7751

28. Chevallier-GrecoA

ManetE

ChavrierP

MosnierC

DaillieJ

1986 Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J 5 3243 3249

29. HardwickJM

LiebermanPM

HaywardSD

1988 A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. J Virol 62 2274 2284

30. CasavantNC

LuoMH

RosenkeK

WinegardnerT

ZurawskaA

2006 Potential role for p53 in the permissive life cycle of human cytomegalovirus. J Virol 80 8390 8401

31. JaultFM

JaultJM

RuchtiF

FortunatoEA

ClarkC

1995 Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J Virol 69 6697 6704

32. RosenkeK

SamuelMA

McDowellET

ToerneMA

FortunatoEA

2006 An intact sequence-specific DNA-binding domain is required for human cytomegalovirus-mediated sequestration of p53 and may promote in vivo binding to the viral genome during infection. Virology 348 19 34

33. KudohA

DaikokuT

SugayaY

IsomuraH

FujitaM

2004 Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication. J Virol 78 104 115

34. KudohA

DaikokuT

IshimiY

KawaguchiY

ShirataN

2006 Phosphorylation of MCM4 at sites inactivating DNA helicase activity of the MCM4-MCM6-MCM7 complex during Epstein-Barr virus productive replication. J Virol 80 10064 10072

35. TarakanovaVL

Leung-PinedaV

HwangS

YangCW

MatatallK

2007 Gamma-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication. Cell Host Microbe 1 275 286

36. SatoY

ShirataN

KudohA

IwahoriS

NakayamaS

2009 Expression of Epstein-Barr virus BZLF1 immediate-early protein induces p53 degradation independent of MDM2, leading to repression of p53-mediated transcription. Virology 388 204 211

37. SatoY

KamuraT

ShirataN

MurataT

KudohA

2009 Degradation of Phosphorylated p53 by Viral Protein-ECS E3 Ligase Complex. PLoS Pathog 5 e1000530

38. DengZ

ChenCJ

ZerbyD

DelecluseHJ

LiebermanPM

2001 Identification of acidic and aromatic residues in the Zta activation domain essential for Epstein-Barr virus reactivation. J Virol 75 10334 10347

39. OuYH

ChungPH

SunTP

ShiehSY

2005 p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation. Mol Biol Cell 16 1684 1695

40. KudohA

IwahoriS

SatoY

NakayamaS

IsomuraH

2009 Homologous recombinational repair factors are recruited and loaded onto the viral DNA genome in Epstein-Barr virus replication compartments. J Virol 83 6641 6651

41. FortunatoEA

SpectorDH

1998 p53 and RPA are sequestered in viral replication centers in the nuclei of cells infected with human cytomegalovirus. J Virol 72 2033 2039

42. HsuCH

ChangMD

TaiKY

YangYT

WangPS

2004 HCMV IE2-mediated inhibition of HAT activity downregulates p53 function. EMBO J 23 2269 2280

43. WilcockD

LaneDP

1991 Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes-infected cells. Nature 349 429 431

44. WenW

IwakiriD

YamamotoK

MaruoS

KandaT

2007 Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes. J Virol 81 1037 1042

45. HalderS

MurakamiM

VermaSC

KumarP

YiF

2009 Early events associated with infection of Epstein-Barr virus infection of primary B-cells. PLoS One 4 e7214

46. KallaM

SchmeinckA

BergbauerM

PichD

HammerschmidtW

2010 AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome. Proc Natl Acad Sci U S A 107 850 855

47. HongH

TakahashiK

IchisakaT

AoiT

KanagawaO

2009 Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460 1132 1135

48. LiH

ColladoM

VillasanteA

StratiK

OrtegaS

2009 The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460 1136 1139

49. KawamuraT

SuzukiJ

WangYV

MenendezS

MoreraLB

2009 Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460 1140 1144

50. UtikalJ

PoloJM

StadtfeldM

MaheraliN

KulalertW

2009 Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460 1145 1148

51. MarionRM

StratiK

LiH

MurgaM

BlancoR

2009 A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460 1149 1153

52. NakayamaKI

NakayamaK

2006 Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 6 369 381

53. PetroskiMD

DeshaiesRJ

2005 Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 6 9 20

54. KraftC

VodermaierHC

Maurer-StrohS

EisenhaberF

PetersJM

2005 The WD40 propeller domain of Cdh1 functions as a destruction box receptor for APC/C substrates. Mol Cell 18 543 553

55. SpruckC

StrohmaierH

WatsonM

SmithAP

RyanA

2001 A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1. Mol Cell 7 639 650

56. HaoB

ZhengN

SchulmanBA

WuG

MillerJJ

2005 Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase. Mol Cell 20 9 19

57. HarperJW

BurtonJL

SolomonMJ

2002 The anaphase-promoting complex: it's not just for mitosis any more. Genes Dev 16 2179 2206

58. SkowyraD

CraigKL

TyersM

ElledgeSJ

HarperJW

1997 F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 91 209 219

59. CarranoAC

EytanE

HershkoA

PaganoM

1999 SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1 193 199

60. SutterlutyH

ChatelainE

MartiA

WirbelauerC

SenftenM

1999 p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol 1 207 214

61. TsvetkovLM

YehKH

LeeSJ

SunH

ZhangH

1999 p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol 9 661 664

62. MannDJ

ChildES

SwantonC

LamanH

JonesN

1999 Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus. EMBO J 18 654 663

63. EllisM

ChewYP

FallisL

FreddersdorfS

BoshoffC

1999 Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex. EMBO J 18 644 653

64. YarmishynA

ChildES

ElphickLM

MannDJ

2008 Differential regulation of the cyclin-dependent kinase inhibitors p21(Cip1) and p27(Kip1) by phosphorylation directed by the cyclin encoded by Murine Herpesvirus 68. Exp Cell Res 314 204 212

65. IwahoriS

MurataT

KudohA

SatoY

NakayamaS

2009 Phosphorylation of p27Kip1 by Epstein-Barr Virus Protein Kinase Induces Its Degradation through SCFSkp2 Ubiquitin Ligase Actions during Viral Lytic Replication. J Biol Chem 284 18923 18931

66. WhitehurstCB

NingS

BentzGL

DufourF

GershburgE

2009 The Epstein-Barr virus (EBV) deubiquitinating enzyme BPLF1 reduces EBV ribonucleotide reductase activity. J Virol 83 4345 4353

67. GastaldelloS

HildebrandS

FaridaniO

CallegariS

PalmkvistM

2010 A deneddylase encoded by Epstein-Barr virus promotes viral DNA replication by regulating the activity of cullin-RING ligases. Nat Cell Biol 12 351 361

68. RabutG

PeterM

2008 Function and regulation of protein neddylation. ‘Protein modifications: beyond the usual suspects’ review series. EMBO Rep 9 969 976

69. SompallaeR

GastaldelloS

HildebrandS

ZininN

HassinkG

2008 Epstein-barr virus encodes three bona fide ubiquitin-specific proteases. J Virol 82 10477 10486

70. BornsteinG

BloomJ

Sitry-ShevahD

NakayamaK

PaganoM

2003 Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J Biol Chem 278 25752 25757

71. GottweinE

CullenBR

2010 A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest. J Virol 84 5229 5237

72. AdamsPD

KaelinWGJr

1995 Transcriptional control by E2F. Semin Cancer Biol 6 99 108

73. LiuC

SistaND

PaganoJS

1996 Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F. J Virol 70 2545 2555

74. MauserA

Holley-GuthrieE

ZanationA

YarboroughW

KaufmannW

2002 The Epstein-Barr virus immediate-early protein BZLF1 induces expression of E2F-1 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells. J Virol 76 12543 12552

75. SwensonJJ

MauserAE

KaufmannWK

KenneySC

1999 The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction. J Virol 73 6540 6550

76. LinWC

LinFT

NevinsJR

2001 Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev 15 1833 1844

77. StevensC

SmithL

La ThangueNB

2003 Chk2 activates E2F-1 in response to DNA damage. Nat Cell Biol 5 401 409